On behalf of the nation’s radiation oncologists, the American Society for Radiation Oncology expressed strong support for Wednesday’s Senate introduction of bipartisan federal legislation that would rein in restrictive prior authorization practices delaying patient access to critical cancer treatments.
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
